Central Pharmaceuticals (DHA:CENTRALPHL) Change In Payables And Accrued Expense : BDT0.00 Mil (TTM As of Sep. 2022)

View and export this data going back to 2013. Start your Free Trial

What is Central Pharmaceuticals Change In Payables And Accrued Expense?

Central Pharmaceuticals's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2022 was BDT0.00 Mil. It means Central Pharmaceuticals's Accounts Payable & Accrued Expense stayed the same from Jun. 2022 to Sep. 2022 .

Central Pharmaceuticals's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2023 was BDT0.00 Mil. It means Central Pharmaceuticals's Accounts Payable & Accrued Expense stayed the same from Jun. 2022 to Jun. 2023 .

Central Pharmaceuticals Change In Payables And Accrued Expense Historical Data

The historical data trend for Central Pharmaceuticals's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceuticals Change In Payables And Accrued Expense Chart

Central Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Central Pharmaceuticals Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Jun23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Central Pharmaceuticals Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0.00 Mil.

Central Pharmaceuticals Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Central Pharmaceuticals's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Central Pharmaceuticals (DHA:CENTRALPHL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceuticals Ltd (DHA:CENTRALPHL) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216

Website

https://www.centralphl.com

Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.

Central Pharmaceuticals (DHA:CENTRALPHL) Headlines

No Headlines